|
|
|
Volumn 12 Suppl 1, Issue , 2005, Pages
|
|
Stage I nonseminomatous germ cell tumors: the case for management by risk stratification.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ADULT;
CANCER INVASION;
CANCER STAGING;
COMPARATIVE STUDY;
DISEASE COURSE;
GERM CELL TUMOR;
HUMAN;
IMMUNOHISTOCHEMISTRY;
LYMPH NODE METASTASIS;
LYMPHADENECTOMY;
MALE;
METASTASIS;
METHODOLOGY;
MIDDLE AGED;
MONITORING;
MORTALITY;
NEEDLE BIOPSY;
PATHOLOGY;
PATIENT SELECTION;
PROGNOSIS;
RETROPERITONEUM;
REVIEW;
RISK ASSESSMENT;
STANDARD;
SURVIVAL;
TESTIS TUMOR;
TREATMENT OUTCOME;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIOPSY, NEEDLE;
DISEASE PROGRESSION;
GERMINOMA;
HUMANS;
IMMUNOHISTOCHEMISTRY;
LYMPH NODE EXCISION;
LYMPHATIC METASTASIS;
MALE;
MIDDLE AGED;
MONITORING, PHYSIOLOGIC;
NEOPLASM INVASIVENESS;
NEOPLASM STAGING;
PATIENT SELECTION;
PROGNOSIS;
RETROPERITONEAL SPACE;
RISK ASSESSMENT;
SURVIVAL ANALYSIS;
TESTICULAR NEOPLASMS;
TREATMENT OUTCOME;
|
|
EID: 18244403777
PISSN: 11959479
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (10)
|
|
References (26)
|
